SUPRIYA

Supriya Lifescience Share Price

 

 

Invest in Supriya Lifescience with 2.92X leverage

Invest with MTF

Performance

  • Low
  • ₹666
  • High
  • ₹694
  • 52 Week Low
  • ₹556
  • 52 Week High
  • ₹842
  • Open Price₹685
  • Previous Close₹688
  • Volume121,283
  • 50 DMA₹721.22
  • 100 DMA₹723.16
  • 200 DMA₹705.63

Investment Returns

  • Over 1 Month -10.87%
  • Over 3 Month -15.99%
  • Over 6 Month -0.66%
  • Over 1 Year -12.36%

Smart Investing Starts Here Start SIP with Supriya Lifescience for Steady Growth!

Invest Now

Supriya Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 29.5
  • PEG Ratio
  • 1.9
  • Market Cap Cr
  • 5,384
  • P/B Ratio
  • 5
  • Average True Range
  • 26.05
  • EPS
  • 22.66
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -15.43
  • RSI
  • 37.76
  • MFI
  • 26.42

Supriya Lifescience Financials

Supriya Lifescience Technicals

EMA & SMA

Current Price
₹668.95
-19.1 (-2.78%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹701.62
  • 50 Day
  • ₹721.22
  • 100 Day
  • ₹723.16
  • 200 Day
  • ₹705.63

Resistance and Support

676.2 Pivot Speed
  • R3 714.05
  • R2 703.85
  • R1 686.40
  • S1 658.75
  • S2 648.55
  • S3 631.10

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Supriya Lifescience is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) with over 38 APIs across various therapeutic segments. It exports to 86 countries, supplying high-quality APIs for pharmaceuticals, nutraceuticals, and personal care industries.

Supriya Lifescience has an operating revenue of Rs. 714.66 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 36% is great, ROE of 18% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 18% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 46 which is a POOR score indicating inconsistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Supplies and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Supriya Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-09 Quarterly Results
2025-11-12 Quarterly Results
2025-08-13 Quarterly Results
2025-05-27 Audited Results & Final Dividend
2025-03-10 Others Inter-alia, to consider 1. Appointment of Company Secretary and Compliance Officer of the Company. 2. Other business matters. per share(30%)Final Dividend
Date Purpose Remarks
2025-09-05 FINAL Rs.1.00 per share(50%)Final Dividend
View Supriya Lifescience Dividend History Arrow

Supriya Lifescience F&O

Supriya Lifescience Shareholding Pattern

68.3%
0.67%
2.32%
5.19%
0%
16.66%
6.86%

About Supriya Lifescience

  • NSE Symbol
  • SUPRIYA
  • BSE Symbol
  • 543434
  • Managing Director
  • Ms. Saloni Satish Wagh
  • ISIN
  • INE07RO01027

Similar Stocks to Supriya Lifescience

Supriya Lifescience FAQs

Supriya Lifescience share price is ₹668 As on 06 February, 2026 | 03:07

The Market Cap of Supriya Lifescience is ₹5383.9 Cr As on 06 February, 2026 | 03:07

The P/E ratio of Supriya Lifescience is 29.5 As on 06 February, 2026 | 03:07

The PB ratio of Supriya Lifescience is 5 As on 06 February, 2026 | 03:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23